Skip to Content

Dihydroxyaluminum sodium carbonate Disease Interactions

There are 2 disease interactions with dihydroxyaluminum sodium carbonate:

Major

Aluminum-containing antacids (applies to dihydroxyaluminum sodium carbonate) constipation

Major Potential Hazard, High plausibility. Applicable conditions: Renal Dysfunction, Intestinal Obstruction, Phosphate Imbalance

Aluminum containing antacids may produce constipation, which may lead to intestinal obstruction. Osteomalacia and hypophosphatemia may be produced in patients with renal dysfunction who are not receiving dialysis. Patients with renal dysfunction, intestinal obstruction, osteomalacia, or hypophosphatemia should use antacids with low or no aluminum content.

References

  1. "Product Information. Losospan (magaldrate)." Whitehall-Robbins, Madison, NJ.
  2. "Product Information. Amphojel (aluminum hydroxide)." Wyeth-Ayerst Laboratories, Philadelphia, PA.
  3. "Product Information. Rolaids (dihydroxyaluminum sodium carbonate)." Warner Lambert Laboratories, Morris Plains, NJ.
Moderate

Sodium-containing antacid (applies to dihydroxyaluminum sodium carbonate) hypernatremia

Moderate Potential Hazard, High plausibility. Applicable conditions: Hypertension, Congestive Heart Failure

The sodium content of antacids may be significant. Patients with hypertension, congestive heart failure, or those on restricted sodium diets should use an antacid with a low sodium content.

References

  1. "Product Information. Rolaids (dihydroxyaluminum sodium carbonate)." Warner Lambert Laboratories, Morris Plains, NJ.

Dihydroxyaluminum sodium carbonate drug interactions

There are 208 drug interactions with dihydroxyaluminum sodium carbonate

Dihydroxyaluminum sodium carbonate alcohol/food interactions

There are 2 alcohol/food interactions with dihydroxyaluminum sodium carbonate

Drug Interaction Classification

These classifications are only a guideline. The relevance of a particular drug interaction to a specific individual is difficult to determine. Always consult your healthcare provider before starting or stopping any medication.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No interaction information available.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.